LyphoMed Inc is raising 70 mln dlrsthrough an offering of convertible subordinatred debentures due2012 with a 5-1/2 pct coupon and par pricing, said lead managerAlex Brown and Sons Inc.    The debentures are convertible into the company's commonstock at 36.25 dlrs per share, representing a premium of 27.75pct over the stock price when terms on the debt were set.    Non-callable for two years, the issue is rated BB byStandard and Poor's Corp. Montgomery Securities co-managed thedeal. Reuter&#3;